On-cell Saturation Transfer Difference (STD) NMR on ion channels: characterizing negative allosteric modulator binding interactions of P2X7.
Serena MonacoiD, Jacob Browne, Matthew WallaceiD, Jesus AnguloiD, Leanne StokesiD
Abstract
P2X7 receptors are important drug targets involved in pathologies ranging from psychiatric disorders to cancer. Being membrane embedded receptors, they are challenging for structural characterisation and at present we only have a small number of X-ray and cryoEM structures for P2X7 bound to antagonists. We demonstrate that Saturation Transfer Difference (STD) NMR on live mammalian cells (on-cell STD NMR) overexpressing P2X7 receptors allows further structural insight on the complexes of P2X7 with two potent negative allosteric modulators, namely AZ10606120 and JNJ-47465567, via the determination of the binding epitope mapping of the interactions e.g. the main region of contact between the ligand and the binding pocket. This approach, reported for the first time on membrane-embedded ion channels, in combination with molecular docking, allows us to propose the first NMR-validated 3D molecular models for two antagonists as bound to human P2X7 receptors, and to correlate the structural knowledge acquired with the pharmacology data. We highlight the transformative potential of this application to aid drug design efforts in a less resource-demanding fashion than X-ray crystallography and cryo-EM and we envisage on-cell STD NMR to fast become an asset for structure-activity-relationship studies helping knowledge-based development of efficient drugs targeting P2X7 and other ion channels/membrane-embedded proteins.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural insights into the orthosteric inhibition of P2X receptors by non-ATP-analog antagonists
D. Sheng, C. Yue, … M. Hattori·bioRxiv·Sep 15, 2023
- Structural insights into the allosteric inhibition of P2X4 receptors
C. Shen, W. Cui, … M. Hattori·bioRxiv·Mar 7, 2023
- Structural insights into the human P2X1 receptor and ligand interactions
Felix M. Bennetts, Hariprasad Venugopal, … David M. Thal·Nature CommunicationsPeer-reviewed·Sep 28, 2024
- UB-MBX-46 is a potent and selective antagonist of the human P2X7 receptor developed by structure-based drug design
Adam C. Oken, Andreea L. Turcu, … Steven Mansoor·bioRxiv·Feb 12, 2025
- Cryo-EM reveals the structural basis of subtype-specific, noncompetitive inhibition of the human P2X3 receptor
Zhixuan Zhao, Dong-Ping Wang, … Motoyuki Hattori·bioRxiv·Jan 3, 2026
- Differential interactions of resting, activated, and desensitized states of the α7 nicotinic acetylcholine receptor with lipidic modulators
Y. Zhuang, C. M. Noviello, … E. Lindahl·bioRxiv·Apr 8, 2022